Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RCEL AVITA Medical Inc
- Stocks
- Healthcare
- NASDAQ: RCEL
Price (delayed)
$6.46
Market cap
$170.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.19
Enterprise value
$199.97M
AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection
Highlights
The gross profit has grown by 40% year-on-year and by 11% since the previous quarter
The revenue has grown by 39% YoY and by 12% from the previous quarter
The net income has contracted by 27% YoY but it has grown by 8% from the previous quarter
The company's EPS fell by 24% YoY but it rose by 8% QoQ
AVITA Medical's equity has shrunk by 114% YoY
RCEL's quick ratio has dropped by 74% year-on-year and by 30% since the previous quarter
Key stats
What are the main financial stats of RCEL
Market
Valuations
Earnings
Shares outstanding
26.43M
Market cap
$170.77M
Enterprise value
$199.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
2.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.79
Revenue
$71.66M
Gross profit
$61.25M
Operating income
-$51.21M
Net income
-$57.05M
EBIT
-$51.78M
EBITDA
-$49.49M
Free cash flow
-$46.63M
Per share
Balance sheet
Liquidity
EPS
-$2.19
EPS diluted
-$2.19
Free cash flow per share
-$1.78
Book value per share
-$0.17
Revenue per share
$2.73
TBVPS
$2.44
Total assets
$69.56M
Total liabilities
$74.06M
Debt
$44.07M
Equity
-$4.57M
Working capital
$25.01M
Debt to equity
-9.64
Current ratio
2.09
Quick ratio
1.65
Net debt/EBITDA
-0.59
Margins
Efficiency
Dividend
EBITDA margin
-69.1%
Gross margin
85.5%
Net margin
-79.6%
Operating margin
-71.5%
Return on assets
-71.7%
Return on equity
-632.6%
Return on invested capital
-59.9%
Return on capital employed
-111.1%
Return on sales
-72.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RCEL stock price
How has the AVITA Medical stock price performed over time
Intraday
1.41%
1 week
-7.32%
1 month
-28.38%
1 year
-18.43%
YTD
-49.53%
QTD
-20.64%
Financial performance
How have AVITA Medical's revenue and profit performed over time
Revenue
$71.66M
Gross profit
$61.25M
Operating income
-$51.21M
Net income
-$57.05M
Gross margin
85.5%
Net margin
-79.6%
The gross profit has grown by 40% year-on-year and by 11% since the previous quarter
The revenue has grown by 39% YoY and by 12% from the previous quarter
The net income has contracted by 27% YoY but it has grown by 8% from the previous quarter
RCEL's operating margin is up by 26% YoY and by 19% from the previous quarter
Price vs fundamentals
How does RCEL's price correlate with its fundamentals
Growth
What is AVITA Medical's growth rate over time
Valuation
What is AVITA Medical stock price valuation
P/E
N/A
P/B
N/A
P/S
2.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.79
The company's EPS fell by 24% YoY but it rose by 8% QoQ
AVITA Medical's equity has shrunk by 114% YoY
The P/S is 78% below the 5-year quarterly average of 10.7 and 42% below the last 4 quarters average of 4.1
The revenue has grown by 39% YoY and by 12% from the previous quarter
Efficiency
How efficient is AVITA Medical business performance
AVITA Medical's return on equity has shrunk by 87% QoQ
The return on assets has dropped by 51% year-on-year
The company's return on sales rose by 18% QoQ and by 12% YoY
The ROIC has contracted by 2.7% from the previous quarter
Dividends
What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RCEL.
Financial health
How did AVITA Medical financials performed over time
The total assets is 6% smaller than the total liabilities
RCEL's quick ratio has dropped by 74% year-on-year and by 30% since the previous quarter
AVITA Medical's current ratio has shrunk by 71% YoY and by 26% QoQ
RCEL's debt to equity has dropped by 196% since the previous quarter
AVITA Medical's equity has shrunk by 114% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.